BVI buries remains of rinderpest disease

The transfer of rinderpest-infected material follows an agreement between BVI and the African Union - Pan Vaccine Centre (PANVAC), under which a facility in Ethiopia was designated for biosafety of all post rinderpest material. These were previously used to manufacture the rinderpest vaccine.

BVI has had an immense contribution to the global eradication of the disease, when the centre started in 1985 to produce normal vaccines, followed by themostable vaccines (unaffected by relatively high temperatures) in 1994. These vaccines were exported to various markets around the world.